niacin has been researched along with Breast Neoplasms in 15 studies
Niacin: A water-soluble vitamin of the B complex occurring in various animal and plant tissues. It is required by the body for the formation of coenzymes NAD and NADP. It has PELLAGRA-curative, vasodilating, and antilipemic properties.
vitamin B3 : Any member of a group of vitamers that belong to the chemical structural class called pyridines that exhibit biological activity against vitamin B3 deficiency. Vitamin B3 deficiency causes a condition known as pellagra whose symptoms include depression, dermatitis and diarrhea. The vitamers include nicotinic acid and nicotinamide (and their ionized and salt forms).
nicotinic acid : A pyridinemonocarboxylic acid that is pyridine in which the hydrogen at position 3 is replaced by a carboxy group.
Breast Neoplasms: Tumors or cancer of the human BREAST.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In the present study, eighty-four breast cancer patients were randomized to receive a daily supplement of 100 mg co-enzyme Q10, 10 mg riboflavin and 50 mg niacin (CoRN), one dosage per d along with 10 mg tamoxifen twice per d." | 9.13 | Co-enzyme Q10, riboflavin and niacin supplementation on alteration of DNA repair enzyme and DNA methylation in breast cancer patients undergoing tamoxifen therapy. ( Premkumar, VG; Sachdanandam, P; Shanthi, P; Yuvaraj, S, 2008) |
| "The prognostic significance of supplementing co-enzyme Q(10) (CoQ(10)), riboflavin and niacin (CoRN) along with tamoxifen to breast cancer patients was evaluated by measuring the serum cytokine levels of interleukin (IL)-1beta, IL-6, IL-8, tumour necrosis factor alpha (TNF-alpha) and vascular endothelial growth factor." | 9.12 | Serum cytokine levels of interleukin-1beta, -6, -8, tumour necrosis factor-alpha and vascular endothelial growth factor in breast cancer patients treated with tamoxifen and supplemented with co-enzyme Q(10), riboflavin and niacin. ( Gangadaran, SG; Premkumar, VG; Sachdanandam, P; Vijayasarathy, K; Yuvaraj, S, 2007) |
| " Tamoxifen (TAM) is a non-steroidal anti-estrogen drug most widely used as an adjuvant hormonal therapy in breast cancer." | 7.74 | Augmented antioxidant status in Tamoxifen treated postmenopausal women with breast cancer on co-administration with Coenzyme Q10, Niacin and Riboflavin. ( Gangadaran, SG; Premkumar, VG; Sachdanandam, P; Vijayasarathy, K; Yuvaraj, S, 2008) |
| " In the present study, 84 breast cancer patients were randomized to receive a daily supplement of 100 mg coenzyme Q10 (CoQ10), 10 mg riboflavin and 50 mg niacin (CoRN) one dosage per day along with 10 mg tamoxifen (TAM) twice a day." | 6.73 | Effect of coenzyme Q10, riboflavin and niacin on serum CEA and CA 15-3 levels in breast cancer patients undergoing tamoxifen therapy. ( Gangadaran, SG; Premkumar, VG; Sachdanandam, P; Vijayasarathy, K; Yuvaraj, S, 2007) |
| "In the present study, eighty-four breast cancer patients were randomized to receive a daily supplement of 100 mg co-enzyme Q10, 10 mg riboflavin and 50 mg niacin (CoRN), one dosage per d along with 10 mg tamoxifen twice per d." | 5.13 | Co-enzyme Q10, riboflavin and niacin supplementation on alteration of DNA repair enzyme and DNA methylation in breast cancer patients undergoing tamoxifen therapy. ( Premkumar, VG; Sachdanandam, P; Shanthi, P; Yuvaraj, S, 2008) |
| "The prognostic significance of supplementing co-enzyme Q(10) (CoQ(10)), riboflavin and niacin (CoRN) along with tamoxifen to breast cancer patients was evaluated by measuring the serum cytokine levels of interleukin (IL)-1beta, IL-6, IL-8, tumour necrosis factor alpha (TNF-alpha) and vascular endothelial growth factor." | 5.12 | Serum cytokine levels of interleukin-1beta, -6, -8, tumour necrosis factor-alpha and vascular endothelial growth factor in breast cancer patients treated with tamoxifen and supplemented with co-enzyme Q(10), riboflavin and niacin. ( Gangadaran, SG; Premkumar, VG; Sachdanandam, P; Vijayasarathy, K; Yuvaraj, S, 2007) |
| " Tamoxifen (TAM) is a non-steroidal anti-estrogen drug most widely used as an adjuvant hormonal therapy in breast cancer." | 3.74 | Augmented antioxidant status in Tamoxifen treated postmenopausal women with breast cancer on co-administration with Coenzyme Q10, Niacin and Riboflavin. ( Gangadaran, SG; Premkumar, VG; Sachdanandam, P; Vijayasarathy, K; Yuvaraj, S, 2008) |
| " Tamoxifen (TAM), a nonsteroidal anti-estrogen drug most used in the chemotherapy and chemoprevention of breast cancer." | 3.73 | Augmented efficacy of tamoxifen in rat breast tumorigenesis when gavaged along with riboflavin, niacin, and CoQ10: effects on lipid peroxidation and antioxidants in mitochondria. ( Perumal, SS; Sachdanandam, P; Shanthi, P, 2005) |
| " In the present study, 84 breast cancer patients were randomized to receive a daily supplement of 100 mg coenzyme Q10 (CoQ10), 10 mg riboflavin and 50 mg niacin (CoRN) one dosage per day along with 10 mg tamoxifen (TAM) twice a day." | 2.73 | Effect of coenzyme Q10, riboflavin and niacin on serum CEA and CA 15-3 levels in breast cancer patients undergoing tamoxifen therapy. ( Gangadaran, SG; Premkumar, VG; Sachdanandam, P; Vijayasarathy, K; Yuvaraj, S, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.67) | 18.7374 |
| 1990's | 2 (13.33) | 18.2507 |
| 2000's | 7 (46.67) | 29.6817 |
| 2010's | 5 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdel-Mohsen, MA | 1 |
| Abdel Malak, CA | 1 |
| El-Shafey, ES | 1 |
| Tabrizi, L | 1 |
| Abyar, F | 1 |
| Elangovan, S | 1 |
| Pathania, R | 1 |
| Ramachandran, S | 1 |
| Ananth, S | 1 |
| Padia, RN | 1 |
| Lan, L | 1 |
| Singh, N | 1 |
| Martin, PM | 1 |
| Hawthorn, L | 1 |
| Prasad, PD | 1 |
| Ganapathy, V | 1 |
| Thangaraju, M | 1 |
| Santolla, MF | 1 |
| De Francesco, EM | 1 |
| Lappano, R | 1 |
| Rosano, C | 1 |
| Abonante, S | 1 |
| Maggiolini, M | 1 |
| Wallach, I | 1 |
| Jaitly, N | 1 |
| Lilien, R | 1 |
| ROSS, V | 1 |
| Perumal, SS | 1 |
| Shanthi, P | 3 |
| Sachdanandam, P | 7 |
| Premkumar, VG | 6 |
| Yuvaraj, S | 6 |
| Vijayasarathy, K | 5 |
| Gangadaran, SG | 5 |
| Jacobson, EL | 1 |
| Shieh, WM | 1 |
| Huang, AC | 1 |
| Baghurst, PA | 1 |
| Carman, JA | 1 |
| Syrette, JA | 1 |
| Baghurst, KI | 1 |
| Crocker, JM | 1 |
3 trials available for niacin and Breast Neoplasms
| Article | Year |
|---|---|
Effect of coenzyme Q10, riboflavin and niacin on serum CEA and CA 15-3 levels in breast cancer patients undergoing tamoxifen therapy.
Topics: Aged; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoembryonic Antigen; Coenzymes; Dietar | 2007 |
Serum cytokine levels of interleukin-1beta, -6, -8, tumour necrosis factor-alpha and vascular endothelial growth factor in breast cancer patients treated with tamoxifen and supplemented with co-enzyme Q(10), riboflavin and niacin.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Breast Neoplasms; Coenzymes; Cytokines; Drug Therapy, | 2007 |
Co-enzyme Q10, riboflavin and niacin supplementation on alteration of DNA repair enzyme and DNA methylation in breast cancer patients undergoing tamoxifen therapy.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Breast Neoplasms; Dietary Supplements; DNA Methylation | 2008 |
12 other studies available for niacin and Breast Neoplasms
| Article | Year |
|---|---|
Influence of copper (I) nicotinate complex and autophagy modulation on doxorubicin-induced cytotoxicity in HCC1806 breast cancer cells.
Topics: Apoptosis; Autophagy; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Survival; Copper; Doxorub | 2019 |
De Novo Design of Cu(II) Complex Containing CNC-Pincer-Vitamin B3 and B7 Conjugates for Breast Cancer Application.
Topics: Antineoplastic Agents; Apoptosis; Biotin; Breast Neoplasms; Copper; DNA; DNA Cleavage; Drug Stabilit | 2019 |
The niacin/butyrate receptor GPR109A suppresses mammary tumorigenesis by inhibiting cell survival.
Topics: Animals; Breast Neoplasms; Butyrates; Cell Survival; Cell Transformation, Neoplastic; Cells, Culture | 2014 |
Niacin activates the G protein estrogen receptor (GPER)-mediated signalling.
Topics: Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; ErbB Receptors; Extracellular | 2014 |
A structure-based approach for mapping adverse drug reactions to the perturbation of underlying biological pathways.
Topics: Breast Neoplasms; Computational Biology; Databases, Factual; Diabetes Mellitus, Type 2; Drug-Related | 2010 |
Nicotinamide in adenocarcinoma 755 and in the milk of mice carrying the agent of spontaneous mammary tumor.
Topics: Adenocarcinoma; Animals; Breast Neoplasms; Humans; Mammary Neoplasms, Animal; Mice; Milk; Neoplasms, | 1957 |
Augmented efficacy of tamoxifen in rat breast tumorigenesis when gavaged along with riboflavin, niacin, and CoQ10: effects on lipid peroxidation and antioxidants in mitochondria.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Administration, Oral; Animals; Antioxidants; Body Weight; Breast N | 2005 |
Ameliorating effect of coenzyme Q10, riboflavin and niacin in tamoxifen-treated postmenopausal breast cancer patients with special reference to lipids and lipoproteins.
Topics: Adult; Aged; Breast Neoplasms; Cholesterol, LDL; Cholesterol, VLDL; Coenzymes; Drug Therapy, Combina | 2007 |
Augmented antioxidant status in Tamoxifen treated postmenopausal women with breast cancer on co-administration with Coenzyme Q10, Niacin and Riboflavin.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Antioxidants; Breast Neoplasms; Enzymes; Female; Human | 2008 |
Effect of Coenzyme Q(10), Riboflavin and Niacin on Tamoxifen treated postmenopausal breast cancer women with special reference to blood chemistry profiles.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Blood Chemical Analysis; Breast Neoplasms; Dietary Sup | 2009 |
Mapping the role of NAD metabolism in prevention and treatment of carcinogenesis.
Topics: Animals; Breast Neoplasms; Humans; Lung Neoplasms; NAD; Neoplasms; Niacin; Rats; Skin; Skin Neoplasm | 1999 |
Diet, prolactin, and breast cancer.
Topics: Adult; Aged; Ascorbic Acid; Breast Neoplasms; Diet; Dietary Fats; Estrogens; Fatty Acids; Female; Hu | 1992 |